Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Two Different Doses of Remifentanil on Bleeding and Hemodynamics in Femur Surgery
IRCT20240929063203N3Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Nov 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of remifentanil in general anesthesia (2 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoints: Intraoperative bleeding and Hemodynamic parameters. Started Nov 2025; status: completed.
02
Drugs
remifentanil
03
Conditions
general anesthesia
Beyond the preview
Go deeper on IRCT20240929063203N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240929063203N3.